TLSIW TriSalus Life Sciences, Inc.: institutional ownership and insider trading
6 funds reported holding $1.87M of TriSalus Life Sciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $14.5K, with 0 new positions and 2 funds selling out; over the last 12 months insiders bought $3.61M and sold $140K on the open market.
Largest institutional holders of TLSIW
- Graypoint LLC — $1.08M
- Cerity Partners LLC — $662K
- ARISTEIA CAPITAL, L.L.C. — $56.9K
- Vestcor Inc — $54.0K
- Fort Baker Capital Management LP — $21.1K
- TORONTO DOMINION BANK (TD, TDBCP) — $3.93K
Recent TLSIW insider trades
- Oct 5, 2026: Stevens Jennifer sold 316 shares ($1.39K)
- Oct 5, 2026: Marshak Richard sold 325 shares ($1.43K)
- Oct 5, 2026: Cox Bryan F. sold 296 shares ($1.30K)
- May 15, 2026: Marshak Richard sold 543 shares ($1.45K)
5%+ owners
- Frankenius Equity AB: 14.0% (Schedule 13D/A, filed Aug 4, 2025)
- First Light Asset Management, LLC: 10.7% (Schedule 13G/A, filed Jul 7, 2026)
- Mats Wahlstrom: 6.0% (Schedule 13D/A, filed Aug 1, 2025)
- Utmost Group PLC: 5.7% (Schedule 13G, filed May 12, 2026)
- James J. Pallotta: 5.2% (Schedule 13G/A, filed May 20, 2026)